{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T16:53:50Z","timestamp":1792601630233,"version":"4.5.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2010,5,27]],"date-time":"2010-05-27T00:00:00Z","timestamp":1274918400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"published-print":{"date-parts":[[2010,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Metabolic syndrome (MetS) is composed of cardiovascular risk factors including insulin resistance, obesity, dyslipidemia, and hypertension. Most of the components of MetS have been linked to the development of neoplasm. The purpose of this study was to evaluate the relationship between individual components of MetS and colorectal adenoma.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>The study subjects were recruited from a pool of 4872 individuals who underwent a health check-up examination during the period January 2006 to May 2008. Each participant fulfilled a structured questionnaire. MetS was defined based on the America Heart Association and National Heart Lung Blood Institute criteria. Subjects with history of colon cancer, colon polyps, colitis, or prior colonic surgery were excluded.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>A total of 4122 subjects were included for final analysis (2367 men and 1755 women; mean age, 49.6 \u00b1 11.7 years). Of them, MetS was diagnosed in 708 men (29.9%) and in 367 women (20.9%). Among the patients with MetS, 34.6% had adenoma, 31.7% had hyperplastic polyps and 23.3% were polyp-free (p &lt; 0.0001, Chi-square test). The adjusted OR for colorectal adenoma was significantly higher in the subjects with MetS (OR, 1.31, CI: 1.09-1.57). A stronger association between MetS and colorectal adenoma was found in men (OR:1.44, CI:1.16-1.80) than in women (OR:1.04, CI:0.74-1.46). The adjusted OR for adenoma increased as the number of MetS components increased (p for trend = 0.0001 ). When the individual components of MetS were analyzed separately, only central obesity (OR:1.36, CI:1.14-1.63), low HDL cholesterol levels (OR:1.30, CI:1.10-1.54) and high triglyceride levels (OR:1.26, CI:1.04-1.53) were independently associated with colorectal adenoma.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Of the components of MetS analyzed in this study, central obesity and dyslipidemia are independent risk factors for colorectal adenoma. With regard to the prevention of colorectal neoplasm, life-style modification such as weight reduction is worthwhile.<\/jats:p><\/jats:sec>","DOI":"10.1186\/1471-230x-10-51","type":"journal-article","created":{"date-parts":[[2010,5,27]],"date-time":"2010-05-27T18:15:08Z","timestamp":1274984108000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":98,"title":["Central obesity and atherogenic dyslipidemia in metabolic syndrome are associated with increased risk for colorectal adenoma in a Chinese population"],"prefix":"10.1186","volume":"10","author":[{"given":"Chiu-Shong","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua-Shui","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chia-Ing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chia-Ing","family":"Jan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsai-Chung","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Yuan","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsann","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya-Chien","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng-Chun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng-Chieh","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,5,27]]},"reference":[{"issue":"9B","key":"442_CR1","doi-asserted-by":"publisher","first-page":"25F","DOI":"10.1016\/S0002-9149(99)00211-8","volume":"83","author":"SM Grundy","year":"1999","unstructured":"Grundy SM: Hypertriglyceridemia, insulin resistance, and the metabolic syndrome. Am J Cardiol. 1999, 83 (9B): 25F-29F. 10.1016\/S0002-9149(99)00211-8.","journal-title":"Am J Cardiol"},{"issue":"5","key":"442_CR2","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.2337\/diabetes.52.5.1210","volume":"52","author":"CM Alexander","year":"2003","unstructured":"Alexander CM, Landsman PB, Teutsch SM, Haffner SM: NCEP-defined metabolic syndrome, diabetes, and prevalence of coronary heart disease among NHANES III participants age 50 years and older. Diabetes. 2003, 52 (5): 1210-1214. 10.2337\/diabetes.52.5.1210.","journal-title":"Diabetes"},{"key":"442_CR3","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1146\/annurev.med.56.082103.104751","volume":"56","author":"DE Moller","year":"2005","unstructured":"Moller DE, Kaufman KD: Metabolic syndrome: a clinical and molecular perspective. Annu Rev Med. 2005, 56: 45-62. 10.1146\/annurev.med.56.082103.104751.","journal-title":"Annu Rev Med"},{"issue":"17","key":"442_CR4","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1056\/NEJMoa021423","volume":"348","author":"EE Calle","year":"2003","unstructured":"Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ: Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med. 2003, 348 (17): 1625-1638. 10.1056\/NEJMoa021423.","journal-title":"N Engl J Med"},{"issue":"2","key":"442_CR5","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1001\/jama.293.2.194","volume":"293","author":"SH Jee","year":"2005","unstructured":"Jee SH, Ohrr H, Sull JW, Yun JE, Ji M, Samet JM: Fasting serum glucose level and cancer risk in Korean men and women. JAMA. 2005, 293 (2): 194-202. 10.1001\/jama.293.2.194.","journal-title":"JAMA"},{"issue":"2","key":"442_CR6","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1002\/ijc.21354","volume":"118","author":"A Lukanova","year":"2006","unstructured":"Lukanova A, Bjor O, Kaaks R, Lenner P, Lindahl B, Hallmans G, Stattin P: Body mass index and cancer: results from the Northern Sweden Health and Disease Cohort. Int J Cancer. 2006, 118 (2): 458-466. 10.1002\/ijc.21354.","journal-title":"Int J Cancer"},{"key":"442_CR7","volume-title":"Taiwan Cancer Registry 2008","author":"Bureau of Health Promotion, Department of Health, Taiwan","year":"2010","unstructured":"Bureau of Health Promotion, Department of Health, Taiwan: Taiwan Cancer Registry 2008. 2010, Accessed: March 22, [http:\/\/www.bhp.doh.gov.tw\/BHPnet\/English\/index.aspx]"},{"key":"442_CR8","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1016\/S0889-8553(02)00057-2","volume":"31","author":"E Giovannucci","year":"2002","unstructured":"Giovannucci E: Modifiable risk factors for colon cancer. Gastroenterol Clin North Am. 2002, 31: 925-43. 10.1016\/S0889-8553(02)00057-2.","journal-title":"Gastroenterol Clin North Am"},{"issue":"1","key":"442_CR9","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1158\/1055-9965.133.14.1","volume":"14","author":"PJ Limburg","year":"2005","unstructured":"Limburg PJ, Anderson KE, Johnson TW, Jacobs DR, Lazovich D, Hong CP, Nicodemus KK, Folsom AR: Diabetes mellitus and subsite-specific colorectal cancer risks in the Iowa Women's Health Study. Cancer Epidemiol Biomarkers Prev. 2005, 14 (1): 133-137.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"1","key":"442_CR10","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1002\/cncr.21950","volume":"107","author":"RL Ahmed","year":"2006","unstructured":"Ahmed RL, Schmitz KH, Anderson KE, Rosamond WD, Folsom AR: The metabolic syndrome and risk of incident colorectal cancer. Cancer. 2006, 107 (1): 28-36. 10.1002\/cncr.21950.","journal-title":"Cancer"},{"issue":"4","key":"442_CR11","first-page":"385","volume":"11","author":"LA Colangelo","year":"2002","unstructured":"Colangelo LA, Gapstur SM, Gann PH, Dyer AR, Liu K: Colorectal cancer mortality and factors related to the insulin resistance syndrome. Cancer Epidemiol Biomarkers Prev. 2002, 11 (4): 385-391.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"9","key":"442_CR12","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1111\/j.1440-1746.2005.03971.x","volume":"20","author":"YY Wang","year":"2005","unstructured":"Wang YY, Lin SY, Lai WA, Liu PH, Sheu WH: Association between adenomas of rectosigmoid colon and metabolic syndrome features in a Chinese population. J Gastroenterol Hepatol. 2005, 20 (9): 1410-1415. 10.1111\/j.1440-1746.2005.03971.x.","journal-title":"J Gastroenterol Hepatol"},{"issue":"4","key":"442_CR13","first-page":"485","volume":"6","author":"T Morita","year":"2005","unstructured":"Morita T, Tabata S, Mineshita M, Mizoue T, Moore MA, Kono S: The metabolic syndrome is associated with increased risk of colorectal adenoma development: the Self-Defense Forces health study. Asian Pac J Cancer Prev. 2005, 6 (4): 485-489.","journal-title":"Asian Pac J Cancer Prev"},{"issue":"8","key":"442_CR14","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1158\/1055-9965.EPI-07-0199","volume":"16","author":"JH Kim","year":"2007","unstructured":"Kim JH, Lim YJ, Kim YH, Sung IK, Shim SG, Oh SO, Park SS, Yang S, Son HJ, Rhee PL, et al: Is metabolic syndrome a risk factor for colorectal adenoma?. Cancer Epidemiol Biomarkers Prev. 2007, 16 (8): 1543-1546. 10.1158\/1055-9965.EPI-07-0199.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"17","key":"442_CR15","doi-asserted-by":"publisher","first-page":"2735","DOI":"10.1161\/CIRCULATIONAHA.105.169404","volume":"112","author":"SM Grundy","year":"2005","unstructured":"Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, Gordon DJ, Krauss RM, Savage PJ, Smith SC, et al: Diagnosis and management of the metabolic syndrome: an American Heart Association\/National Heart, Lung, and Blood Institute Scientific Statement. Circulation. 2005, 112 (17): 2735-2752. 10.1161\/CIRCULATIONAHA.105.169404.","journal-title":"Circulation"},{"issue":"10","key":"442_CR16","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1056\/NEJM199203053261002","volume":"326","author":"WS Atkin","year":"1992","unstructured":"Atkin WS, Morson BC, Cuzick J: Long-term risk of colorectal cancer after excision of rectosigmoid adenomas. N Engl J Med. 1992, 326 (10): 658-662. 10.1056\/NEJM199203053261002.","journal-title":"N Engl J Med"},{"issue":"6","key":"442_CR17","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1038\/oby.2008.216","volume":"16","author":"GE Lee","year":"2008","unstructured":"Lee GE, Park HS, Yun KE, Jun SH, Kim HK, Cho SI, Kim JH: Association between BMI and metabolic syndrome and adenomatous colonic polyps in Korean men. Obesity (Silver Spring). 2008, 16 (6): 1434-1439. 10.1038\/oby.2008.216.","journal-title":"Obesity (Silver Spring)"},{"issue":"5","key":"442_CR18","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.2353\/ajpath.2006.051090","volume":"169","author":"S Cowey","year":"2006","unstructured":"Cowey S, Hardy RW: The metabolic syndrome: A high-risk state for cancer?. Am J Pathol. 2006, 169 (5): 1505-1522. 10.2353\/ajpath.2006.051090.","journal-title":"Am J Pathol"},{"issue":"3","key":"442_CR19","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1079\/PNS200194","volume":"60","author":"P Trayhurn","year":"2001","unstructured":"Trayhurn P, Beattie JH: Physiological role of adipose tissue: white adipose tissue as an endocrine and secretory organ. Proc Nutr Soc. 2001, 60 (3): 329-339. 10.1079\/PNS200194.","journal-title":"Proc Nutr Soc"},{"issue":"3","key":"442_CR20","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1079\/BJN20041213","volume":"92","author":"P Trayhurn","year":"2004","unstructured":"Trayhurn P, Wood IS: Adipokines: inflammation and the pleiotropic role of white adipose tissue. Br J Nutr. 2004, 92 (3): 347-355. 10.1079\/BJN20041213.","journal-title":"Br J Nutr"},{"issue":"6","key":"442_CR21","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1158\/1055-9965.EPI-06-0042","volume":"15","author":"MJ Gunter","year":"2006","unstructured":"Gunter MJ, Canzian F, Landi S, Chanock SJ, Sinha R, Rothman N: Inflammation-related gene polymorphisms and colorectal adenoma. Cancer Epidemiol Biomarkers Prev. 2006, 15 (6): 1126-1131. 10.1158\/1055-9965.EPI-06-0042.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"1","key":"442_CR22","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1158\/0008-5472.CAN-07-2924","volume":"68","author":"S Kim","year":"2008","unstructured":"Kim S, Keku TO, Martin C, Galanko J, Woosley JT, Schroeder JC, Satia JA, Halabi S, Sandler RS: Circulating levels of inflammatory cytokines and risk of colorectal adenomas. Cancer Res. 2008, 68 (1): 323-328. 10.1158\/0008-5472.CAN-07-2924.","journal-title":"Cancer Res"},{"issue":"9","key":"442_CR23","first-page":"937","volume":"10","author":"M Trevisan","year":"2001","unstructured":"Trevisan M, Liu J, Muti P, Misciagna G, Menotti A, Fucci F: Markers of insulin resistance and colorectal cancer mortality. Cancer Epidemiol Biomarkers Prev. 2001, 10 (9): 937-941.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"3","key":"442_CR24","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1001\/jama.288.3.321","volume":"288","author":"JE Rossouw","year":"2002","unstructured":"Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, Jackson RD, Beresford SA, Howard BV, Johnson KC, et al: Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. JAMA. 2002, 288 (3): 321-333. 10.1001\/jama.288.3.321.","journal-title":"JAMA"},{"issue":"10","key":"442_CR25","doi-asserted-by":"publisher","first-page":"2609","DOI":"10.1158\/1055-9965.EPI-08-0385","volume":"17","author":"C Ritenbaugh","year":"2008","unstructured":"Ritenbaugh C, Stanford JL, Wu L, Shikany JM, Schoen RE, Stefanick ML, Taylor V, Garland C, Frank G, Lane D, et al: Conjugated equine estrogens and colorectal cancer incidence and survival: the Women's Health Initiative randomized clinical trial. Cancer Epidemiol Biomarkers Prev. 2008, 17 (10): 2609-2618. 10.1158\/1055-9965.EPI-08-0385.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"1","key":"442_CR26","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1158\/0008-5472.CAN-07-2946","volume":"68","author":"MJ Gunter","year":"2008","unstructured":"Gunter MJ, Hoover DR, Yu H, Wassertheil-Smoller S, Rohan TE, Manson JE, Howard BV, Wylie-Rosett J, Anderson GL, Ho GY, et al: Insulin, insulin-like growth factor-I, endogenous estradiol, and risk of colorectal cancer in postmenopausal women. Cancer Res. 2008, 68 (1): 329-337. 10.1158\/0008-5472.CAN-07-2946.","journal-title":"Cancer Res"},{"key":"442_CR27","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/1471-230X-6-5","volume":"6","author":"IK Larsen","year":"2006","unstructured":"Larsen IK, Grotmol T, Almendingen K, Hoff G: Lifestyle as a predictor for colonic neoplasia in asymptomatic individuals. BMC Gastroenterol. 2006, 6: 5-10.1186\/1471-230X-6-5.","journal-title":"BMC Gastroenterol"}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-230X-10-51.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-230X-10-51\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-230X-10-51","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-230X-10-51.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,27]],"date-time":"2024-03-27T02:53:12Z","timestamp":1711507992000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcgastroenterol.biomedcentral.com\/articles\/10.1186\/1471-230X-10-51"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,5,27]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["442"],"URL":"https:\/\/doi.org\/10.1186\/1471-230x-10-51","relation":{},"ISSN":["1471-230X"],"issn-type":[{"value":"1471-230X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,5,27]]},"assertion":[{"value":"4 December 2009","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2010","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2010","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"51"}}